Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

First Wave Biopharma Inc (FWBI)

First Wave Biopharma Inc (FWBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,424
  • Shares Outstanding, K 12,461
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,670 K
  • 60-Month Beta 1.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FWBI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.63
  • Number of Estimates 2
  • High Estimate -0.60
  • Low Estimate -0.67
  • Prior Year -3.10
  • Growth Rate Est. (year over year) +79.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8101 +7.18%
on 11/24/21
3.0900 -37.22%
on 11/01/21
-0.7400 (-27.61%)
since 10/26/21
3-Month
1.8101 +7.18%
on 11/24/21
7.0500 -72.48%
on 09/10/21
-4.2990 (-68.91%)
since 08/26/21
52-Week
1.8101 +7.18%
on 11/24/21
26.3000 -92.62%
on 01/22/21
-5.8710 (-75.16%)
since 11/25/20

Most Recent Stories

More News
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis

Committee members include globally renowned experts in medical oncology, immune checkpoint inhibitor therapeutics, gastrointestinal (GI) diseases and...

FWBI : 1.9400 (-1.02%)
First Wave BioPharma Announces FDA Clearance of IND Application for Phase 2a PASSPORT Trial of FW-ICI-AC as Treatment for Immune Checkpoint Inhibitor-Associated Colitis

BOCA RATON, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a...

FWBI : 1.9400 (-1.02%)
First Wave BioPharma Announces Two Additions to Scientific Advisory Board

Globally Recognized Experts in Gastrointestinal Diseases, Cystic Fibrosis and Virology to Support Company in Advancing Niclosamide and Adrulipase Clinical...

FWBI : 1.9400 (-1.02%)
First Wave BioPharma Begins Patient Screening for Phase 2b Clinical Trial Evaluating Niclosamide in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis

Preliminary data from prior Phase 1a/2a trial indicated safety of topical formulation of FW-UP and suggested possible favorable efficacy

FWBI : 1.9400 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

First Wave BioPharma Inc. is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. First Wave BioPharma Inc., formerly known as AzurRx BioPharma Inc., is based in BOCA RATON, Fla.

See More

Key Turning Points

3rd Resistance Point 2.0800
2nd Resistance Point 2.0200
1st Resistance Point 1.9800
Last Price 1.9400
1st Support Level 1.8800
2nd Support Level 1.8200
3rd Support Level 1.7800

See More

52-Week High 26.3000
Fibonacci 61.8% 16.9449
Fibonacci 50% 14.0551
Fibonacci 38.2% 11.1652
Last Price 1.9400
52-Week Low 1.8101

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar